Dengue fever classification

Dengue Fever Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dengue fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dengue fever classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dengue fever classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dengue fever classification

CDC on Dengue fever classification

Dengue fever classification in the news

Blogs on Dengue fever classification

Directions to Hospitals Treating Dengue fever

Risk calculators and risk factors for Dengue fever classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Alonso Alvarado, M.D. [2]

## Overview

[edit | edit source]

Current WHO guideline classifies dengue into non-severe and severe disease depending on whether there is severe plasma leakage, severe bleeding, or severe organ impairment. For practical purposes, non-severe cases can be further divided into two subgroups: those with warning signs and those without them. Patients with suspected dengue should be triaged and managed accordingly.

## Classification

[edit | edit source]

### 1997 WHO Classification

[edit | edit source]

Historically, symptomatic dengue virus infections were classified as dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. The case definitions were found too difficult to apply in resource-limited settings and too specific, as it failed to identify a substantial proportion of severe dengue cases, including cases of hepatic failure and encephalitis.

The tables below describe the 1997 WHO dengue case classification:[1]

| Dengue Fever

Probable Dengue Fever
❑ An acute febrile illness
PLUS
❑ Two or more of the following manifestations:
❑ Headache
❑ Retro-orbital pain
❑ Myalgia
❑ Arthralgia
❑ Rash
❑ Hemorrhagic manifestations
❑ Leukopenia
PLUS
❑ Supportive serology
❑ A reciprocal hemagglutination-inhibition antibody titre ≥1280
❑ A comparable IgG enzyme-linked immunosorbent assay (ELISA) titer
❑ A positive IgM test on a late acute or convalescent-phase serum specimen
Confirmed Dengue Fever
❑ A case confirmed by laboratory criteria
❑ Isolation of the dengue virus from serum or autopsy samples
❑ Demonstration of a fourfold or greater change in reciprocal IgG or IgM antibody titers to one or more dengue virus antigens in paired serum samples
❑ Demonstration of dengue virus antigen in autopsy tissue, serum or cerebrospinal fluid (CSF) samples by immunohistochemistry, immunofluorescence or ELISA
❑ Detection of dengue virus genomic sequences in autopsy tissue serum or CSF samples by polymerase chain reaction (PCR)
Reportable Dengue Fever
❑ Any probable or confirmed case should be reported
| Dengue Hemorrhagic Fever & Dengue Shock Syndrome

Dengue Hemorrhagic Fever (DHF)
❑ Fever, or history of acute fever, lasting 2–7 days, occasionally biphasic
PLUS
❑ Hemorrhagic tendencies, evidenced by at least one of the following:
❑ A positive tourniquet test†
❑ Petechiae, ecchymoses, or purpura
❑ Bleeding from the mucosa, gastrointestinal tract, injection sites or other locations
❑ Hematemesis or melena
PLUS
❑ Thrombocytopenia (100,000 cells per mm3 or less)
PLUS
❑ Evidence of plasma leakage due to increased vascular permeability, manifested by at least one of the following:
❑ A rise in the hematocrit equal to or greater than 20% above average for age, sex and population
❑ A drop in the hematocrit following volume-replacement treatment equal to or greater than 20% of baseline
❑ Signs of plasma leakage such as pleural effusion, ascites and hypoproteinemia
Dengue Shock Syndrome (DSS)
❑ All of the above four criteria for DHF must be present
PLUS
❑ Evidence of circulatory failure manifested by:
❑ Rapid and weak pulse AND narrow pulse pressure
❑ OR manifested by:
❑ Hypotension for age AND cold, clammy skin and restlessness

† The tourniquet test is performed by inflating a blood pressure cuff on the upper arm to a point midway between the systolic and diastolic pressures for 5 minutes. A test is considered positive when 20 or more petechiae per 2.5 cm (1 inch) square are observed. The test may be negative or mildly positive during the phase of profound shock. It usually becomes positive, sometimes strongly positive, if the test is conducted after recovery from shock.

### 2009 WHO Classification

[edit | edit source]

A newer classification published by WHO in 2009 categorizes the disease into probable dengue or laboratory-confirmed dengue (with or without warning signs) and severe dengue (encompassing severe plasma leakage, severe bleeding, and severe organ involvement). However, it has been criticized as overly inclusive for several reasons:[2]

* It allows several different ways to qualify for severe dengue.
* Nonspecific warning signs are used as diagnostic criteria.
* Severity determination is dependent on individual judgment due to the lack of explicit clinical criteria for establishing severe dengue.

The tables below describe the 2009 WHO dengue case classification:[3][4]

| Dengue ± Warning Signs

Probable Dengue (live in or travel to dengue endemic area)
❑ Fever
PLUS
❑ Two of the following criteria:
❑ Nausea or vomiting
❑ Rash
❑ Aches and pains
❑ Tourniquet test positive†
❑ Leukopenia
❑ Any warning sign
Warning Signs
❑ Warning signs requiring strict observation and medical intervention:
❑ Abdominal pain or tenderness
❑ Persistent vomiting
❑ Clinical fluid accumulation
❑ Mucosal bleed
❑ Lethargy, restlessness
❑ Liver enlargment >2 cm
❑ Increase in hematocrit with rapid decrease in platelet count
| Severe Dengue

Severe Plasma Leakage
❑ Severe plasma leakage leading to:
❑ Shock (dengue shock syndrome)
❑ Fluid accumulation with respiratory disrtess
Severe Bleeding
❑ Severe bleeding as evaluated by clinician:
❑ Persistent and/or severe overt bleeding in the presence of unstable hemodynamic status, regardless of the hematocrit level
❑ A decrease in hematocrit after fluid resuscitation together with unstable hemodynamic status
❑ Refractory shock unresposive to fluid resuscitation of 40–60 ml/kg
❑ Hypotensive shock with low/normal hematocrit before fluid resuscitation
❑ Persistent or worsening metabolic acidosis ± a well-maintained systolic blood pressure, especially in those with severe abdominal tenderness and distension
Severe Organ Involvement
❑ Severe organ involvement indicated by:
❑ Liver: AST or ALT ≥1000 IU/L
❑ CNS: impaired consciousness
❑ Heart or other organs

† The tourniquet test is performed by inflating a blood pressure cuff on the upper arm to a point midway between the systolic and diastolic pressures for 5 minutes. A test is considered positive when 20 or more petechiae per 2.5 cm (1 inch) square are observed. The test may be negative or mildly positive during the phase of profound shock. It usually becomes positive, sometimes strongly positive, if the test is conducted after recovery from shock.

#### Laboratory Tests for Confirmed and Probable Dengue Infection

[edit | edit source]

* A diagnosis of confirmed dengue infection is established by isolation of the virus, detection of viral genome or NS1 antigen, or seroconversion of IgM or IgG (from negative to positive IgM/IgG or fourfold increase in the specific antibody titer) in paired sera.

* A positive IgM serology or a hemagglutination inhibition assay (HIA) antibody titer of 1280 or higher (or comparable figures by ELISA in a single specimen), are diagnostic of a probable dengue infection. Both probable and confirmed dengue cases should be notified to health authorities.[3]

Definition | Method† | Interpretation† | Sample Characteristics

|
|
|

Confirmed Dengue Infection  | Viral isolation  | Virus isolated  | Serum (collected at 1–5 days of fever) or necropsy tissues
Genome detection  | Positive RT-PCR or positive real-time RT-PCR
Antigen detection  | Positive NS1 Ag
Positive immunohistochemical  | Necropsy tissues
IgM seroconversion  | From negative IgM to positive IgM in paired sera  | Acute serum (days 1–5) and convalescent serum (15–21 days after first serum)
IgG seroconversion  | From negative IgG to positive IgG in paired sera or 4-fold increase IgG levels among paired sera
Probable Dengue Infection  | Positive IgM  | Positive IgM  | Single serum collected after day 5
High IgG levels  | High IgG levels by ELISA or hemagglutination inhibition assay (≥1280)

† ELISA = enzyme-linked immunosorbent assay; IgG = immunoglobulin G; IgM = immunoglobulin M; NS1 Ag = non-structural protein 1 antigen; RT-PCR = reverse transcriptase polymerase chain reaction

## Referemces

[edit | edit source]

1. ↑ "Dengue haemorrhagic fever: diagnosis, treatment, prevention and control" (PDF).
2. ↑ "Infectious Diseases Related To Travel".
3. ↑ 3.0 3.1 "Handbook for Clinical Management of dengue" (PDF).
4. ↑ "Dengue: guidelines for diagnosis, treatment, prevention and control" (PDF).